These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of dermatologic conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in dermatologic care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career dermatology professionals will benefit from these educational grant–supported sessions. Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.

Medical dermatology often leaves patients with visible sequelae that continue to affect quality of life after active disease is controlled. Dyspigmentation, scarring, textural change, volume loss, and post-inflammatory changes all require careful assessment and realistic counseling. This session explores cosmetic and procedural strategies that can help restore skin health while accounting for the underlying dermatologic condition, risk of flare, pigmentary change, and patient goals.

Inflammatory wounds are frequently mistaken for infection, vascular disease, trauma, or nonhealing surgical wounds, which can delay appropriate treatment and worsen outcomes. Using pyoderma gangrenosum as a central example, this session examines diagnostic clues, biopsy considerations, systemic associations, pathergy risk, and treatment escalation. Special attention will be given to common missteps, including unnecessary debridement and delayed immunosuppression.

Ocular inflammation may be an early sign of systemic immune-mediated disease or a serious complication in patients already being treated for dermatologic conditions. This session reviews key ocular manifestations relevant to dermatology, including uveitis, episcleritis, scleritis, keratitis, conjunctivitis, and periocular inflammation. The discussion will focus on red flags, referral urgency, and how ocular findings may influence systemic treatment planning.

Advanced cutaneous squamous cell carcinoma requires timely recognition, risk stratification, and coordinated care across dermatology, surgery, oncology, and radiation oncology. This session reviews treatment strategy for high-risk, locally advanced, recurrent, and metastatic disease, including the evolving role of immunotherapy. Practical considerations include staging, referral timing, treatment sequencing, response assessment, and management of complex or immunosuppressed patients.

Skin findings can sometimes signal deeper systemic inflammation, including cardiovascular involvement. This session introduces cardiac imaging concepts relevant to dermatologists caring for patients with autoimmune, inflammatory, or infiltrative disease. Topics include when echocardiography, cardiac MRI, CT, PET imaging, or other modalities may be useful, along with clinical clues that should prompt collaboration with cardiology.

Menopause affects the skin, hair, mucosa, and vulvar health in ways that are often under-recognized in dermatology practice. This session reviews hormonal influences on xerosis, barrier dysfunction, pruritus, hair changes, vulvar dermatoses, genitourinary symptoms, and skin sensitivity. Emphasis will be placed on practical evaluation, treatment options, patient counseling, and coordination with gynecology when symptoms extend beyond routine dermatologic care.

The widespread use of GLP-1 receptor agonists and related anti-obesity therapies has introduced new dermatologic and aesthetic considerations. Rapid weight loss, metabolic shifts, nutritional changes, and altered body composition may contribute to facial volume loss, laxity, hair shedding, xerosis, intertrigo, and wound-healing concerns. This session offers a practical approach to recognizing these changes, distinguishing them from unrelated skin disease, and guiding patients seeking medical or cosmetic management.

Nonsteroidal topical therapies are expanding options for children with chronic inflammatory skin disease, particularly for sensitive areas, maintenance treatment, and steroid-sparing care. This session reviews targeted topical agents and how they fit into pediatric treatment plans alongside corticosteroids, calcineurin inhibitors, phototherapy, and systemic therapies. Practical guidance will address safety, tolerability, application counseling, adherence, and building regimens that families can realistically follow.

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of dermatologic conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in dermatologic care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career dermatology professionals will benefit from these educational grant–supported sessions. Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.

Alopecia areata has entered a new treatment era, shaped by a deeper understanding of immune pathways and expanding therapeutic options. This session connects disease mechanisms with real-world treatment selection, monitoring, relapse, durability of response, and long-term management. The focus will be on approaching alopecia areata as a chronic immune-mediated disease, with attention to severity, comorbidities, safety, patient goals, and counseling.

Melanoma care continues to evolve quickly, with advances in immunotherapy, targeted therapy, adjuvant and neoadjuvant treatment, response assessment, and toxicity management. This session translates key oncology developments into practical knowledge for dermatologists involved in diagnosis, referral, surveillance, and long-term patient care. The discussion will also address treatment-related skin findings and how systemic therapy decisions shape follow-up in dermatology practice.

Pregnancy can alter the course of inflammatory and autoimmune skin disease, while treatment decisions must account for maternal disease control, fetal safety, and lactation planning. This session reviews practical management considerations for conditions such as psoriasis, atopic dermatitis, lupus-related skin disease, hidradenitis suppurativa, pemphigoid gestationis, and other complex dermatoses. The emphasis is on medication selection, flare management, risk communication, and coordination with maternal-fetal medicine.

Autoimmune blistering diseases require early recognition, careful testing, and individualized treatment planning. This session offers a practical framework for evaluating blistering disorders, including morphology, biopsy technique, direct and indirect immunofluorescence, serologies, and key clinical differentiators. Treatment discussion will include corticosteroids, steroid-sparing agents, biologics, infection prevention, wound care, and monitoring for complications.

Diagnosis and treatment in skin of color require attention to morphology, pigmentary response, scarring risk, hair practices, cultural context, and patient priorities. This session reviews practical diagnostic pearls for common and complex dermatologic conditions that may present differently across skin tones. Topics include inflammatory disease, pigmentary disorders, acne, alopecia, procedural planning, and counseling around post-inflammatory hyperpigmentation or hypopigmentation.

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of dermatologic conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in dermatologic care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career dermatology professionals will benefit from these educational grant–supported sessions. Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.

Anti-obesity medications and weight-loss procedures can produce gastrointestinal effects that influence adherence, nutrition, quality of life, and downstream dermatologic concerns. This session reviews common tolerability issues, including nausea, vomiting, constipation, reflux, diarrhea, malabsorption, nutritional deficiencies, and post-procedural complications. The discussion will help dermatology clinicians better understand the GI context behind skin, hair, and wound-related changes seen during weight-loss treatment.

Some rashes require immediate recognition and decisive action. This session focuses on high-stakes dermatologic emergencies, including SJS/TEN, DRESS, acute generalized exanthematous pustulosis, erythroderma, and other severe cutaneous adverse reactions. The session will emphasize early warning signs, medication history, triage, biopsy and lab workup, inpatient coordination, and treatment decisions that can change outcomes.

Non-scarring alopecia includes a broad range of conditions beyond alopecia areata, from telogen effluvium and androgenetic alopecia to traction alopecia, nutritional contributors, endocrine disorders, and medication-related hair loss. This session reviews diagnostic patterns, history-taking, scalp examination, laboratory evaluation, and treatment approaches. Special attention will be given to identifying reversible causes and counseling patients on realistic timelines for regrowth.

Immune checkpoint inhibitors have transformed cancer treatment across melanoma and many other tumor types, creating new opportunities and new toxicities for dermatologists to understand. This session reviews current and emerging uses of checkpoint blockade, mechanisms of response and resistance, combination strategies, and future directions in immuno-oncology. Dermatology-relevant considerations include cutaneous immune-related adverse events, coordination with oncology, and the expanding role of dermatologists in supportive cancer care.

Inflammatory bowel disease is closely linked to dermatologic disease, both through shared inflammatory pathways and treatment-related effects. This session reviews common and complex skin manifestations of IBD, including erythema nodosum, pyoderma gangrenosum, aphthous disease, psoriasis, hidradenitis suppurativa overlap, and medication-associated eruptions. The discussion will highlight how GI disease activity, biologic selection, paradoxical reactions, and multidisciplinary coordination influence skin outcomes.

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of dermatologic conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in dermatologic care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career dermatology professionals will benefit from these educational grant–supported sessions. Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.

Immune checkpoint inhibitors can cause a broad spectrum of cutaneous toxicities, ranging from mild eruptions to severe inflammatory, autoimmune, and blistering disorders. This session focuses on practical oncodermatology management, including grading toxicity, selecting topical or systemic treatment, determining when therapy can continue, and recognizing when urgent oncology coordination is needed. The goal is to support effective cancer treatment while minimizing dermatologic morbidity.

Cutaneous T-cell lymphoma can mimic common inflammatory dermatoses, leading to delayed diagnosis and uncertainty in management. This session reviews clinical clues, biopsy strategy, staging workup, and treatment selection for CTCL in everyday dermatology practice. Topics include early-stage disease, skin-directed therapies, systemic options, monitoring, referral timing, and communication with patients who may face a prolonged diagnostic journey.

Rare cutaneous tumors can be easy to miss but may carry significant morbidity or mortality when diagnosis is delayed. This session reviews high-risk clinical clues, diagnostic pathways, staging considerations, and treatment advances for uncommon skin cancers and adnexal tumors. Emphasis will be placed on recognizing when a lesion does not fit routine patterns, when to escalate evaluation, and how multidisciplinary care shapes outcomes.

Cutaneous sarcoidosis can present with a wide range of morphologies and may provide the first clue to systemic disease. This session reviews clinical patterns, biopsy findings, systemic evaluation, and treatment options for localized and widespread disease. The discussion will connect skin findings with pulmonary, ocular, cardiac, neurologic, and other systemic considerations, helping dermatologists determine when broader workup or specialty referral is needed.

Pigmented lesions involving the eye and periocular region can raise important diagnostic and referral questions for dermatologists. This session reviews key features of benign and malignant pigmented ocular lesions, including when ocular melanoma should be considered. The discussion will address clinical warning signs, referral pathways, imaging and diagnostic evaluation, treatment advances, and dermatology's role in recognizing lesions that require ophthalmic oncology expertise.

The spectrum of neutrophilic dermatoses continues to expand as new disease entities, evolving diagnostic criteria, and emerging targeted therapies reshape clinical practice. This session provides a practical update on disorders including Sweet syndrome, pyoderma gangrenosum, neutrophilic eccrine hidradenitis, bowel-associated dermatosis-arthritis syndrome, and VEXAS syndrome, highlighting the clinical features that distinguish these often-overlapping conditions.

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of dermatologic conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in dermatologic care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career dermatology professionals will benefit from these educational grant–supported sessions. Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of dermatologic conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in dermatologic care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career dermatology professionals will benefit from these educational grant–supported sessions. Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.

Scarring alopecias require early recognition and prompt treatment to prevent irreversible hair loss. This session focuses on lichen planopilaris and related cicatricial alopecias, including diagnostic clues, trichoscopic findings, biopsy strategy, disease activity assessment, and treatment escalation. The discussion will include anti-inflammatory approaches, symptom control, patient counseling, and long-term monitoring for stabilization rather than full regrowth.

Chronic itch is increasingly understood as a complex neuroimmune process with distinct pathways, triggers, and treatment targets. This session reviews emerging mechanisms in pruritus, including inflammatory signaling, neural sensitization, barrier dysfunction, and systemic contributors. The discussion will connect evolving science with therapeutic development, helping clinicians better classify itch, identify underlying drivers, and consider new or emerging treatment approaches.

Dermatologic diagnosis is moving beyond morphology alone, with biomarkers, molecular profiling, and precision medicine tools beginning to shape classification and treatment decisions. This session explores emerging diagnostic approaches across inflammatory disease, skin cancer, and complex dermatoses. Topics include tissue and blood-based biomarkers, molecular signatures, treatment-response prediction, and how precision diagnostics may change clinical workflows in the coming years.

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of dermatologic conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in dermatologic care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career dermatology professionals will benefit from these educational grant–supported sessions. Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.

These highly interactive educational sessions offer a comprehensive and practical look into a diverse array of dermatologic conditions. With a focus on translating current research into practical, real-world applications, these sessions will help you to effectively integrate the latest advances in dermatologic care into clinical practice, enhancing your professional skills and improving patient outcomes. Both seasoned and early-career dermatology professionals will benefit from these educational grant–supported sessions. Applications for commercial support from healthcare-related industries are pending. Commercial support will be acknowledged as it is received.

Dermatology practices continue to face growing pressure from drug pricing, payer restrictions, prior authorization, staffing challenges, reimbursement shifts, and patient affordability concerns. This session examines operational strategies for navigating access barriers while preserving quality of care and practice sustainability. Topics include biologic and specialty medication workflows, patient support programs, team roles, financial counseling, documentation, and adapting practice systems to a more complex treatment environment.

Artificial intelligence is rapidly entering dermatology through image analysis, documentation support, triage, patient communication, clinical decision support, and practice operations. This session takes a practical look at where AI may help, where it can create risk, and how dermatology practices can evaluate tools responsibly. Discussion will include workflow integration, bias, privacy, documentation, liability, patient trust, and safeguards needed before adopting AI in routine care.

Billing and coding changes can have a direct impact on dermatology practice operations, compliance, reimbursement, and clinician workflow. This session reviews key updates relevant to dermatology and explains what they mean in day-to-day practice. The focus will be on practical application, including documentation habits, coding accuracy, common errors, audit readiness, and steps practices can take to prepare teams for changes without creating unnecessary administrative burden.